RT Journal Article
SR Electronic
T1 Forecasting the Spread of COVID-19 under Different Reopening Strategies
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.26.20113993
DO 10.1101/2020.05.26.20113993
A1 Liu, Meng
A1 Thomadsen, Raphael
A1 Yao, Song
YR 2020
UL http://medrxiv.org/content/early/2020/05/29/2020.05.26.20113993.abstract
AB We combine COVID-19 case data with demographic and mobility data to estimate a modified susceptible-infected-recovered (SIR) model for the spread of this disease in the United States. We find that the incidence of infectious COVID-19 individuals has a concave effect on contagion, as would be expected if people have inter-related social networks. We also demonstrate that social distancing and population density have large effects on the rate of contagion. The social distancing in late March and April substantially reduced the number of COVID-19 cases. However, the concave contagion pattern means that when social distancing measures are lifted, the growth rate is considerable but will not be exponential as predicted by standard SIR models. Furthermore, counties with the lowest population density could likely avoid high levels of contagion even with no social distancing. We forecast rates of new cases for COVID-19 under different social distancing norms and find that if social distancing is eliminated there will be a massive increase in the cases of COVID-19, about double what would occur if the US only restored to 50% of the way to normalcy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Only publicly available (or corporate-owned but available to all academic researchers) data was used.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesMost of the data we use is publicly available from multiple sources, and we lay out our sources ad where researchers can access this data clearly. Cell phone stay-at-home rates are from SafeGraph, which is available for free from all researchers studying COVID-19. We cannot share this data, but it is widely available, so the paper is auditable.